Bio-Path Holdings Inc Stock Nasdaq
Equities
US09057N1028
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.16M 5.69M |
---|---|---|---|---|---|
Net income 2024 * | -12M -16.4M | Net income 2025 * | -13M -17.76M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.14
x | P/E ratio 2025 * |
-0.14
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.89% |
Latest transcript on Bio-Path Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 07-05-09 | |
Peter Nielsen
CEO | Chief Executive Officer | 75 | 07-05-09 |
Douglas Morris
FOU | Founder | 68 | 07-05-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Morris
FOU | Founder | 68 | 07-05-09 |
Heath Cleaver
BRD | Director/Board Member | 51 | 14-02-10 |
Peter Nielsen
CEO | Chief Executive Officer | 75 | 07-05-09 |
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |